Evidence map›Paper›PMID 30206010›Full record

ArticleJournal of cardiothoracic and vascular anesthesia2019

Noninvasive Administration of Inhaled Nitric Oxide and its Hemodynamic Effects in Patients With Acute Right Ventricular Dysfunction.

Jan-Alexis Tremblay, Étienne J Couture, Martin Albert, William Beaubien-Souligny, Mahsa Elmi-Sarabi, Yoan Lamarche, André Y Denault

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cardiothoracic and vascular anesthesia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Gas mixture in noninvasive ventilation.Medical gas research · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jan-Alexis TremblayDepartment of Medicine, Division of Critical Care, Université de Montréal, Montreal, QC, Canada.
Étienne J CoutureDepartment of Medicine, Division of Critical Care, Université de Montréal, Montreal, QC, Canada.
Martin AlbertDepartment of Medicine, Division of Critical Care, Université de Montréal, Montreal, QC, Canada; Department of Medicine and Critical Care, Sacré-Coeur Hospital and Montreal Heart Institute, Montreal, QC, Canada.
William Beaubien-SoulignyDepartment of Medicine, Division of Nephrology, Université de Montréal, Montreal, QC, Canada.
Mahsa Elmi-SarabiDepartment of Anesthesiology and Division of Critical Care, Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada.
Yoan LamarcheDepartment of Medicine and Critical Care, Sacré-Coeur Hospital and Montreal Heart Institute, Montreal, QC, Canada; Department of Cardiac Surgery Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada.
André Y DenaultDepartment of Anesthesiology and Division of Critical Care, Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada; Division of Critical Care, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. Electronic address: andre.denault@gmail.com.
Montreal Heart Institute · CAUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe authors aimed to assess the hemodynamic effects and demonstrate the feasibility of inhaled nitric oxide (iNO) in hemodynamically unstable patients with acute right ventricular (RV) dysfunction and to explore the safety profile of this approach.

designRetrospective cohort study.

settingIntensive care unit (ICU) of 2 tertiary care centers between January 2013 and 2017.

participantsAll patients with RV dysfunction in whom iNO was initiated without invasive mechanical ventilation.

interventionNoninvasive administration of iNO. MEASUREMENTS AND MAIN

resultsEighteen patients received the intervention during the study period; 8 of these patients had a pulmonary artery catheter and 2 had a pulse contour analysis device. Median (interquartile range) iNO concentration was 20 (20-20) ppm, and therapy duration was 24 (12-46) hours. Most patients received iNO through nasal prongs (66.7%) or a high-flow nasal cannula (27.8%). Within 1 hour, iNO reduced pulmonary vascular resistance from 219.1 to 165.4 dyn•s/cm

conclusionNoninvasively administered iNO was associated with favorable hemodynamic effects in ICU patients with acute RV dysfunction. These results suggest the safety and feasibility of this therapy for which further prospective study is warranted.

Indexed as

Acute DiseaseAdministration, InhalationAgedBronchodilator AgentsCardiac OutputCohort StudiesFemaleHemodynamicsHumansMaleMiddle AgedNitric OxideRetrospective StudiesVentricular Dysfunction, RightBronchodilator AgentsNitric Oxideinhaled nitric oxidepulmonary hypertensionright ventricular dysfunction

Identifiers

PMID30206010
OpenAlexW2885783578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.